Intimate partner violence and HIV sexual risk behaviour among women who inject drugs in Indonesia: a respondent‑driven sampling study Claudia Stoicescu, by Stoicescu, Claudia et al.
Stoicescu, C. et al. (2018). Intimate partner violence and HIV sexual risk behaviour among 
women who inject drugs in Indonesia: a respondent-driven sampling study. 
AIDS and Behaviour, 2018.  
http://dx.doi.org/10.1007/s10461-018-2186-2  
 
 
University of the Western Cape Research Repository                                                              Claudia.stoicescu@spi.ox.ac.uk            
 
Intimate partner violence and HIV sexual risk behaviour among 
women who inject drugs in Indonesia: a respondent‑driven 
sampling study 
 
Claudia Stoicescu, Lucie D. Cluver, Thees Spreckelsen, Marisa Casale, Anindita Gabriella 
Sudewo and Irwanto 
 
Abstract 
Women who inject drugs are disproportionately affected by HIV and intimate partner 
violence (IPV); however, the link between IPV and HIV remains under-researched among 
substance-using women in low- and middle-income countries. This study examined 
associations and additive effects of different forms of IPV victimization (psychological, 
physical and/or injurious, and sexual) on HIV sexual risk behavior among women who 
inject drugs in Indonesia. Respondent-driven sampling (RDS) was used to recruit 731 
women from Greater Jakarta and Bandung, West Java. RDS-II weighted prevalence of any 
past-year IPV was 68.9% (95% CI 65.0, 72.6) in Jakarta and 55.9% (95% CI 48.0, 63.5) in 
Bandung. In separate logistic regressions controlling for socio-demographic covariates, all 
three forms of IPV showed statistically significant associations with sexual risk behavior. 
After adjusting for all IPV types, psychological (OR 1.87; 95% CI 1.17, 2.99; p = 0.009) and 
sexual (OR 1.98; 95% CI 1.22, 3.21; p = 0.006) IPV independently predicted women’s sexual 
risk behavior. Marginal effects models suggested that co-occurrence of multiple forms of IPV 
had greater adverse consequences: sexual risk behavior was reported by 64.1% of women 
who did not experience any IPV, but increased to 89.9% among women exposed to all three 
types. Comprehensive harm reduction services that integrate IPV monitoring and prevention 
are urgently needed to reduce both HIV and IPV. 
 
Introduction 
Asia is home to half of the estimated 3.8 million women who inject drugs globally [1]. 
Meta-analytic evidence has established that women who inject drugs experience higher 
levels of HIV than their male counterparts in high prevalence settings [2]. At the same 
time, there is growing recognition that social and structural factors shape individual risks 
and increase vulnerability to HIV via direct and indirect pathways [3, 4]. Intimate 
partner violence (IPV) has been highlighted as a key contributor to HIV transmission 
risk among drug-using women [5]. IPV is also more prevalent among women who inject 
drugs vis-à-vis women in the general population. For example, a recent review identified 
rates of past-year IPV ranging from 20% to 57% among clinical and community-based 
samples of women who use drugs in the United States, which is 2–5 times higher than 
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prevalence rates found among general female populations [6, 7]. In North America, IPV 
victimization against women who inject drugs has been associated with the presence of 
multiple risk factors for sexually-transmitted HIV, including condomless sex, multiple 
sexual partners, history of past or current sexually transmitted infections (STIs), and 
trading sex for money, drugs, or shelter [8]. Different forms of IPV (i.e. psychological, 
physical, and sexual) may increase women’s susceptibility to HIV risk through direct and 
indirect mechanisms. Sexual IPV or forced sex may directly exacerbate women’s HIV risk 
through biological mechanisms, via genital injuries and lacerations that facilitate disease 
transmission [9]. Indirectly, both sexual and physical IPV have been shown to impact HIV 
risk by creating a dynamic of fear and submission that hinders a woman’s ability to 
negotiate safer sex [5]. Psychological abuse may create a similar context of dominance 
and control, which increases women’s likelihood of engaging in risky sexual behaviors 
[10]. In fact, emerging research suggests that psychological aggression has similar 
detrimental effects on women’s health outcomes to physical and sexual forms of IPV [11, 12]. 
 
A growing body of international research has documented strong associations between 
IPV and HIV, both in the general population [13] and among key populations such as 
men who have sex with men and female sex workers [14]. However, extant research 
investigating this association among drug-involved women is geographically clustered in 
high-income countries [5, 15, 16]. Crucially, no published research to date has explored 
this relationship among women who inject drugs in low- and middle- income countries in 
Asia. 
 
In contrast with a trend of stabilisation across most countries in the Asia region, 
Indonesia is facing an escalating HIV epidemic concentrated among key populations 
[17]. With an HIV prevalence of 36.4%, people who inject drugs remain disproportionally 
affected compared with other key populations, such as female and transgender sex 
workers and their clients, and men who have sex with men [18]. Despite their smaller 
numbers compared with their male counterparts, women who inject drugs face elevated 
vulnerability to HIV [19–21]. In 2009, the only year for which sex-disaggregated 
estimates are available, HIV prevalence among women who inject drugs in Indonesia was 
57.1%, relative to 52.1% among male injectors [22]. Furthermore, qualitative studies from 
urban settings across the Indonesian archipelago suggest that IPV and HIV vulnerability 
may co-occur among women who use and inject drugs [19, 20, 23–25]. For instance, in a 
multicity qualitative study of 52 women who use drugs, Habsari et al. identified pervasive 
exposure to violence perpetrated by both intimate and non-intimate partners [19]. Women 
have also reported that in situations where they felt at risk of HIV infection whilst in an 
abusive relationship, their priority was not protection against HIV infection. Instead, 
women sought to avoid conflict out of fear of provoking aggression from their partners, 
and a desire to “maintain their relationship” [25]. However, no quantitative studies to 
date have explored the prevalence and associations of IPV and HIV sexual risk behavior 
among women who inject drugs in Indonesia. 
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Understanding the relationship between different forms of IPV and sexual risk behavior is 
essential for elucidating pathways to HIV and for informing effective interventions with 
women who inject drugs in low-and middle-income countries. There is a clear need for 
quantitative research with adequately sized samples and validated measures, to assess the 
effect of IPV on drug-using women’s HIV risk outcomes in Asia. Accordingly, this study 
examines the largest known sample of Indonesian women who inject drugs to date to 
investigate (1) associations between exposure to psychological, physical and/or injurious, 
and sexual dimensions of IPV and HIV sexual risk behavior; and (2) potential additive 
effects of IPV polyvictimization on women’s sexual risk behavior. 
 
Methods 
Study Design and Sampling 
A cross-sectional design was employed to recruit women who inject drugs from urban areas 
with large numbers of people who inject drugs and high HIV rates among injectors [26]: 
Jakarta and peri-urban surrounding cities Bogor, Tangerang, Depok and Bekasi (hereafter 
referred to as “Greater Jakarta”) and Bandung, the provincial capital of West Java. The 
minimum sample size for this study (709 participants) was calculated by assuming a 36% HIV 
prevalence rate [18], with 95% confidence, 5% precision, and a design effect of 2 [27, 28]. 
 
The community of women who inject drugs was actively engaged in the development, 
implementation, and dissemination of the research. Four focus group discussions with a total of 
39 women, and three consultations with relevant key population networks and community-
based organisations, were convened to ensure that all study procedures were sensitive to the 
needs of participants. A community advisory group comprised of six women with an injecting 
drug use background was established to advise researchers throughout study implementation. 
Once the data were analysed, a consultation was convened to discuss results with peers and 
devise strategies for dissemination. 
 
Between September 2014 and June 2015, 731 women were recruited using respondent-driven 
sampling (RDS). RDS, a modified chain referral sampling method, is known to be effective for 
the recruitment of populations that are hard-to-reach [29]. Akin to snowball sampling, RDS 
utilizes peer networks to recruit participants. However, RDS limits the influence of recruiters 
on the final composition of the sample by restricting the number of recruits per recruiter, and 
weights the sample by participants’ probability of recruitment (social network size) to adjust for 
non-random sampling [30]. Since its introduction in 1997, over 460 RDS studies in 69 
countries have been conducted with hidden or hard-to-reach populations [31]. 
 
Eligibility criteria included: being ≥ 18 years of age; residing in one of the study catchment 
areas; injecting drugs in the preceding 12 months; and possessing a valid recruitment 
referral. Guided by the internationally-supported definition proposed by WHO, UNODC, 
and UNAIDS and by indicators used in national surveillance [26, 32], this study deemed 
women reporting any instance of illicit or illegal drug injecting occurring in the previous 12 
months as eligible [33]. 
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Procedures 
To initiate recruitment, a diverse group of 20 initial recruits (“seeds”) was selected by the 
researchers. Seed selection was informed by extensive formative research, including 
mapping of hotspots where people inject drugs, key informant interviews with local harm 
reduction service providers, and community consultations. To increase the representativeness 
of the sample, selected seeds were heterogeneous in terms of age, education, levels of risk 
behavior, and known HIV status. Each initial recruit was asked to refer up to three peers to 
the study, who in turn enlisted others in a chain-referral fashion. Successive waves of 
recruitment continued until the desired sample size was reached. 
 
Questionnaires were translated into Bahasa Indonesia by bilingual health workers and pre-
tested with women representative of the target sample according to WHO guidelines [34]. 
Seven female peer fieldworkers were trained by senior researchers in mobile-assisted 
interviewing, ethics, and health and safety. Face-to-face interviews lasted approximately 1 h 
and were conducted in the local language at locations deemed safe by participants, such 
as offices of non-governmental organisations or participants’ homes. Information was 
collected using tablets equipped with Open Data Kit, an open-source application for data 
collection and management on mobile devices [35]. 
 
The study used mobile-site interviewing. Potential recruits were asked to contact the 
research team by phone or text message to set up an interview at a location of their choice. 
As part of the RDS process, participants received a primary incentive of 75,000 Indonesian 
Rupiah (~ USD $5) for participating in the interview and a secondary incentive of 25,000 
Indonesian Rupiah (~ USD $2) per eligible peer recruited. Monetary remuneration is 
considered an ethical and effective way to facilitate participation in public health research 
by people who use drugs [36, 37]. Appropriate renumeration was determined by 
consulting the community advisory group and previous bio-behavioral surveys with people 
who inject drugs in Indonesia. Each recruit was given a uniquely coded identifier and recorded 
in SyrEx2, a monitoring and evaluation tool used by drug service providers [38]. 
 
Ethical Considerations 
The study was anonymous, and all participants were encouraged to use a pseudonym. Verbal 
and written voluntary informed consent was obtained from each participant. Consent forms 
were worded in plain language and included clear explanations of the nature and purpose of 
the research, limits to confidentiality in the context of illegal activities, and explicit 
statements regarding participants’ rights to opt-out at any point. Consent forms were read 
and discussed verbally by the interviewers to ensure that participants had the necessary 
information to be able to provide informed consent, regardless of literacy level. 
 
Strict confidentiality was maintained, except where participants requested assistance or 
service referrals. In the case that information disclosed suggested that a participant was at 
risk of significant harm (e.g. severe violence) the interviewer discussed concerns with the 
participant and offered service referrals. Researchers maximised opportunities for 
referral by providing all participants with a local directory of HIV/STI testing and 
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counselling, legal aid, and IPV support services. Interviewers explained to participants 
what existing services they could access for free and how to do so. Ethical protocols were 
approved by the ethics boards at the University of Oxford (ref no: SSD/ CUREC2/13-23) 
and Atma Jaya University (ref no: 1114/ III/LPPM-PM.10.05/11/2013). 
 
Measurement 
HIV Sexual Risk Behavior 
HIV sexual risk behavior in the preceding 12 months was measured using items from the 
UNAIDS Global AIDS Progress Reporting Indicator Registry [39] and informed by WHO 
guidance [40]: (1) condomless sex at last vaginal and/ or anal intercourse; (2) multiple sexual 
partners; and (3) STI symptomatology. Sexually active participants were asked the 
following yes/no question, “Think about the last time you had vaginal and/or anal sex 
with any sexual partner. Did you use a condom the last time you had sex?” Participants 
who responded in the negative were coded as having had condomless sex at last intercourse 
(0 = used condom/not sexually active; 1 = did not use condom at last intercourse). 
Participants were also asked about the total number of sexual partners in the preceding 12 
months. Following previous research [8, 41], multiple sexual partners was operationalized 
as having two or more sexual partners in the previous year. Condomless sex at last 
intercourse and multiple sexual partners included both steady and casual partners and paid 
and unpaid sex. STI symptomatology was assessed using a multiple-choice checklist of six 
easily recognised symptoms (i.e. “burning sensation and/or discomfort when urinating,” 
“itching, irritation and/or discomfort in the genital area,” “discomfort and/or pain during 
sexual intercourse,” “sores, blisters and/or ulcers on or in the vagina,” “unusual vaginal 
discharge, such as pus or a thick and/or sticky liquid from the genital area,” and/or “lower 
abdominal pain”) [40, 42]. STI symptomatology was ascertained if participants reported 
experiencing ≥ 2 symptoms. 
 
A dichotomous variable reflecting women’s HIV sexual risk behavior during the preceding 
12 months was created by coding one or more affirmative responses to the three items 
above as the presence of sexual risk behavior (0 = no sexual risk behavior, 1 = sexual risk 
behavior). Participants who did not endorse any of the three risk behaviors assessed and those 
who were not sexually-active were coded as 0 = no sexual risk behavior. 
 
Intimate Partner Violence 
Intimate partner violence was assessed using the psychological, physical, injurious, and 
sexual subscales of the Revised Conflict Tactics Scale (CTS2) short form [43, 44]. The CTS2 
has been cross-culturally validated in more than 17 countries, including several low- and 
middle-income countries in Asia [45], and is the most widely-used measure assessing IPV 
victimization in community and clinical samples of drug-using women [8, 41, 46]. Sample 
items from each of the subscales include: psychological aggression (“My partner insulted or 
swore or shouted or yelled at me”); physical assault (“My partner punched or kicked or 
beat-me-up”); injurious physical assault (“I went to see a doctor or needed to see a doctor 
because of a fight with my partner”); and sexual coercion (“My partner used force, like 
hitting, holding down, or using a weapon, to make me have sex”). Participants were asked 
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about violence perpetrated by a current or former intimate partner in the preceding 12 
months. Guided by previous research [47, 48], binary variables were created for each type 
of IPV (psychological, physical and/or injurious, and sexual) by assigning a score of 1 if one 
or more instances of the items were reported to have occurred in the past year and 0 if no 
instances were reported. Affirmative responses to IPV victimization items on each subscale 
were coded as 1 regardless of responses to subscales for other IPV types. For this sample the 
CTS2 sub-scales showed adequate to high internal consistency, ranging between α = 0.65 and 
α = 0.82, and totalling α = 0.87 for the full scale. 
 
Sociodemographic and Background Characteristics 
Informed by a literature review and formative research, selected socio-economic and 
background information was collected as the basis for a confounder analysis and potential 
effect modification [8, 20, 41, 49]. Using items modelled on the Indonesia Population Census 
(Statistics Indonesia) and Integrated Biological and Behavioral Surveillance (Ministry of 
Health), women were asked their age, relationship status, employment status, level of 
education, individual monthly income, and whether they had any dependent children in the 
household or other dependents for whom they were responsible. Individual monthly income 
was classified as being either below or above the mean national income in Indonesia [50]. 
Participants were also asked about illegal and/or illicit drug use in the previous 12 months, 
and whether they had knowledge of their HIV status. 
 
Since previous longitudinal research has established a link between drug-using women’s 
financial dependency on their intimate partner and elevated sexual risk behavior [51], a 
variable reflecting this construct was included as a potential confounder. Financial 
dependency was assessed by asking participants about the main source (> 50%) of their 
monthly income. Women were coded as financially dependent if they indicated that their 
main source of income was from intimate partner(s). Furthermore, studies have shown that 
the syndemic co-occurrence and interaction of multiple psychosocial factors may augment 
HIV risk-taking behavior [5, 52, 53]. In particular, as crystal meth has been shown to co-
occur with IPV and heighten HIV risk [54, 55], a dichotomous variable was computed to 
indicate any past-year use of non-injection crystal meth. Following previous research 
indicating that the relationship between IPV, other syndemic factors, and HIV risk may be 
modified by structural influences such as poverty and housing instability [56, 57], a variable 
reflecting women’s housing status was also included. Housing status was assessed by asking 
participants about their current living arrangements and dichotomised into “stable 
housing” vs “unstable housing/homelessness”. Women were coded as “unstably housed 
and/or homeless” if they lived on the street, including in public spaces (i.e. train station) or in 
temporary or transitional accommodation, such as a friend’s home, and “stably housed” if 
they lived in their family home, rental house/apartment, and rental long-term single-room 
accommodation (kos-kosan). All measures were based on self-report. 
 
Statistical Analysis 
Analyses were conducted in four stages: 
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1. Frequencies for all variables were conducted on the unweighted, aggregated sample. 
RDS-II weighted estimates of population proportions and 95% confidence intervals (CIs) 
and sample diagnostics were calculated using the user-written RDS analysis package [58, 59] 
in Stata 14 (StataCorp, College Station, TX). Preliminary analyses revealed that participants 
formed two isolated geographical components with minimal across-group recruitment (i.e. 
bottleneck), which can add variance to a sample and produce unstable estimates [60] (see 
Supplementary Appendix II). In the presence of bottlenecks, standard practice in RDS 
literature is to produce estimates for each sub-sample individually rather than combining 
them into an overall sample [60]. Therefore, weighted estimates and RDS diagnostics for HIV 
sexual risk and IPV variables were computed separately for each study city. However, in 
order to retain the power and precision corresponding to the initial calculated sample 
size, and because city differences can be adjusted for, the unweighted city sub-samples were 
aggregated for subsequent bivariate and multivariate analyses. 
2. Bivariate associations between IPV and background variables and the sexual risk 
behavior outcome were examined using logistic regressions. Variables associated with 
sexual risk behavior at p < 0.1 were retained in multivariate analyses [61]. 
3. To explore the independent effects of each IPV dimension from its overall effect, separate 
multivariate logistic regression models were created for each form of IPV (psychological, 
physical and/or injurious, and sexual), and a final model controlled for all IPV 
dimensions simultaneously. For robustness, we assessed potential multicollinearity 
between predictor variables using variance inflation factor (VIF) diagnostic tests, which 
quantify how much the variance of the estimated regression coefficient is inflated by the 
presence of correlation among the independent variables in the model [62, 63]. The presence 
of multicollinearity was defined as tolerance values below 0.1 and VIF values equal to or 
greater than 10 [62]. For models 1–3 assessing each IPV dimension separately, VIFs for all 
independent variables were lower than 4, mean VIFs for all models were under 2, and 
tolerance values ranged between 0.25 and 0.89. In model 4, which included all IPV 
dimensions, VIFs for predictor variables ranged between 1.14 and 4.10. The mean VIF for 
the entire model was 2.29, which is lower than the accepted threshold of 6, thus indicating 
acceptable fit of the model. In addition, tolerance values for variables in model 4 were 
between 0.24 and 0.88, with no values falling below 0.1. Therefore, no evidence of 
multicollinearity was identified between the predictors analyzed in the present study. We 
also tested for plausible two-way interactions between each dimension of IPV and 
background variables using product terms. No statistically significant interactions were 
detected. 
4. We tested whether sexual risk behavior effects were greater if women experienced 
more than one form of IPV. All IPV variables that were included in model 4 were entered 
into a marginal effects model, adjusting for significant confounders. Predicted 
probabilities of engaging in HIV sexual risk behavior under each potential combination of 
IPV exposures were computed, with significant covariates held at mean values. 
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Results 
RDS Sample Characteristics 
A total of 731 women who inject drugs were recruited into the study, using 18 seeds and 554 
recruits in Greater Jakarta (n = 572) and 2 seeds and 157 recruits in Bandung (n = 159). Five 
seeds, two in Bandung and three in Greater Jakarta, generated 54% (n = 391) of the 
combined sample across the two survey cities. The largest recruitment chain reached up to 
11 waves and contained 105 participants in Greater Jakarta, and 8 waves with 98 
participants in Bandung. Participants’ mean personal network size (degree) was 4.7 (SD = 
4.2, range 1–35) in Greater Jakarta, and 3.9 (SD = 2.0, range 1–21) in Bandung. No 
considerable differentials in mean degree were observed for any of the variables in this 
study. 
 
An RDS sample attains equilibrium when the sample distribution on key variables remains 
stable (i.e. within 2% of cumulative sample proportions) as new recruits are added [64]. 
Convergence refers to the required referral chain length (i.e. depth) necessary to reach 
equilibrium [65]. To determine whether recruitment chains converged to a sampling 
equilibrium, convergence plots superimposing the weighted sample proportions at each 
recruitment wave on the cumulative proportion based on the complete sample were 
examined for select variables (see Supplementary Appendix I) [66]. Proportions for this 
sample appear to stabilize between waves 3–5 for Bandung and waves 2–5 for Greater 
Jakarta and remain stable until the full sample size is attained, indicating that the sample is 
becoming random as additional participants enroll. 
 
Homophily assesses the extent to which participants prefer to recruit those with similar 
characteristics to themselves rather than uniformly at random [64]. We used the homophily 
index (Hx) proposed by Heckathorn, which contains values ranging from − 1.0 to 1.0 [30]. 
Scores close to 0 indicate random recruitment and scores higher than 0.3 (or − 0.3) specify 
substantial in-group contact. Most analysis and outcome variables showed low homophily (all 
Hx < 0.27), indicating a high tendency to recruit others at random. Moderate homophily was 
detected for sexual coercion (Hx = 0.35), such that women from Jakarta who did not 
experience past-year sexual coercion tended to recruit others like themselves 35% of the time 
and at random 65% of the time. 
 
Sociodemographic and background characteristics 
Mean age in the aggregated, unweighted sample was 31.3 years (SD = 5.10 years) 
(Table 2). 20.2% of women completed less than a high school education, 38.7% were 
currently married, and 56.5% had children or other dependents for whom they were 
responsible. Mean individual monthly income was IDR 4.3 million/USD 385 (SD = 3.38), 
with more than half (54.5%) of participants earning less than the average national income 
(IDR 3.8 million ~ USD 285). Nearly half of the women (44.3%) were unemployed, and at 
least one quarter (25.4%) were financially dependent on an intimate partner. 5.3% of the 
women were homeless or unstably housed. 
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Drugs injected in the previous year included heroin (94.4%), illicit buprenorphine 
(19.2%), illicit pharmaceuticals (i.e. largely in the opiate and benzodiazepine class of 
substances, used without a prescription) (4.0%), and crystal methamphetamine (crystal 
meth) (0.8%). Drugs used via non-injection routes of administration, such as smoking, 
snorting, or swallowing, included heroin (93.8%), crystal meth (67.2%) illicit 
pharmaceuticals (46.2%), cannabis (36.3%), and ketamine (6.6%). Self-reported HIV 
prevalence in the sample was 46.7%. 
 
Prevalence of Sexual Risk Behavior and Intimate Partner Violence 
Overall, similar proportions of participants in Greater Jakarta (76.2%; 95% CI 71.4, 
80.5) and Bandung (74.1%; 95% CI 66.2, 80.6) reported one or more of three HIV sexual risk 
behaviors (i.e. condomless sex at last intercourse, STI symptomatology, or multiple sexual 
partners) (Table 1). The prevalence of condomless vaginal and/or anal sex at last 
intercourse ranged from 46.9% (95% CI 39.2, 54.8) in Bandung to 65.1% (95% CI 61.1, 68.8) 
in Greater Jakarta. The prevalence of STI symptomatology was higher in Greater Jakarta 
(52.8%; 95% CI 48.6, 56.8) relative to Bandung (21.2%; 95% CI 15.7, 28.1). However, a 
higher proportion of participants in Bandung reported having multiple sexual partners in 
the preceding year (37.8%; 95% CI 30.5, 45.7), compared with participants from Greater 
Jakarta (25.1%; 95% CI 21.6, 28.9) (Table 2). 
 
There were notable differences in the prevalence of IPV victimization across the two survey 
cities (Table 1). Bandung had a lower prevalence of any form of past-year IPV (55.9%; 95% CI 
48.0, 63.5) relative to Greater Jakarta (68.9%; 95% CI 65.0, 72.6). Participants in Greater 
Jakarta reported higher levels of psychological aggression (58.8%; 95% CI 54.7, 62.8) as 
compared with those in Bandung (52.6%; 95% CI 44.7, 60.3). The prevalence of sexual 
coercion in Greater Jakarta (39.8%; 95% CI 35.7, 44.0) was nearly double that in Bandung 
(19.6%; 95% CI 13.7, 27.3). However, reported levels of physical and/or injurious assault 
were higher in Bandung (42.2%; 95% CI 34.8, 50.0) than in Greater Jakarta (38.8%; 95% CI 
35.0, 42.8). 
 
Bivariate Associations Between IPV and HIV Sexual Risk Behavior 
There were significant positive associations in bivariate analyses between the sexual risk 
behavior outcome and each form of IPV (Table 3): psychological aggression (OR 2.92, 95% 
CI 2.05, 4.16; p < 0.001), physical and/or injurious assault (OR 2.73, 95% CI 1.87,3.98; p < 
0.001), and sexual coercion (OR 2.38, 95% CI 1.54,3.66; p < 0.001). Additionally, there 
were statistically significant associations at p < 0.1 between sexual risk behavior and 
several background variables: crystal meth use (OR 2.47, 95% CI 1.74,3.51; p < 0.001), HIV-
positive status (OR 1.37, 95% CI 0.97, 1.94; p = 0.074), lower than high school educational 
attainment (OR 2.59, 95% CI 1.53, 4.39; p < 0.001), being currently married (OR 0.74, 95% 
CI 0.53, 1.05; p = 0.093), homelessness and/or unstable housing (OR 3.88, 95% CI 
1.18,12.75; p = 0.026), age (OR 0.95, 95% CI 0.91, 0.98; p = 0.002), and survey city (OR 
1.50; 95% CI 1.01, 2.23; p = 0.044). These variables were thus retained in subsequent 
multivariate models. 
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Multivariate Associations Between IPV and HIV Sexual Risk Behavior 
After adjusting for significant covariates, all three forms of IPV were associated with 
elevated odds of engaging in sexual risk behaviors (models 1–3, Table 4). Specifically, 
women who experienced psychological IPV were nearly three times more likely to engage 
in sexual risk behavior (OR 2.77; 95% CI 1.91, 4.03; p < 0.001) relative to women who did 
not experience such abuse. Furthermore, women exposed to physical and/or injurious IPV 
were at least twice more likely to engage in sexual risk behavior (OR 2.49; 95% CI 1.67, 3.70; p 
< 0.001) compared with women who were not exposed to physical and/or injurious IPV. 
Lastly, experiencing sexual IPV nearly tripled the odds of engaging in sexual risk behavior (OR 
2.61; 95% CI 1.65, 4.13; p < 0.001). There were statistically significant positive 
associations between engaging in sexual risk behavior and the following covariates in all 
three multivariate models: crystal meth use, HIV-positive status, younger age, lower than 
high school educational attainment, and not being currently married. 
 
Model 4 (Table 4) included all dimensions of IPV and controlled for significant covariates. 
Psychological aggression (OR 1.87, 95% CI 1.17, 2.99; p = 0.009), and sexual IPV (OR 1.98; 
95% CI 1.22, 3.21; p = 0.006) remained independently positively associated with 
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sexual risk behavior, even after controlling for other IPV dimensions (i.e. physical and/or 
injurious). Furthermore, several background variables remained significantly positively 
associated with sexual risk behavior: crystal meth use (OR 2.27, 95% CI 1.54, 3.35; p < 
0.001), HIV-positive status (OR 1.70, 95% CI 1.15, 2.50; p = 0.007), and lower than high 
school educational attainment (OR 2.53, 95% CI 1.43, 4.50; p = 0.002). Two covariates 
were negatively associated with engaging in sexual risk behavior: age (OR 0.96, 95% CI 
0.92, 1.00; p = 0.040), and marital status (OR 0.50, 95% CI 0.33, 0.76; p = 0.001). 
 
Additive Effects 
The predicted probabilities of the outcome when exposed to co-occurring forms of IPV 
victimization are displayed in Fig. 1. Strong additive effects were shown on women’s 
sexual risk behavior. The prevalence of sexual risk behavior was 64.1% among women 
who did not experience any form of past-year IPV. Among women exposed to any one of 
psychological, physical and/or injurious, or sexual IPV, 72.4–76.9% reported engaging in 
sexual risk behavior. Among women experiencing two co-occurring forms of IPV, levels of 
sexual risk behavior increased to 82.3–85.6%. With polyvictimization of all three forms of 
IPV, the percentage of women reporting sexual risk behavior escalated to 89.9%. 
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Discussion 
Findings from this study suggest that, when considered separately, psychological, physical, 
and sexual dimensions of IPV each has significant effects on sexual risk among women who 
inject drugs in Indonesia. This study found that at least 6 in 10 women who inject drugs were 
exposed to some form of past-year IPV, which is up to 24 times higher than IPV prevalence 
found in the general Indonesian female population [67]. Approximately three quarters of 
women across the two study cities engaged in HIV sexual risk behavior. It is especially 
concerning that nearly half of the women had STI symptoms, since the presence of STIs 
increases the infectiousness of HIV and facilitates HIV transmission [68, 69]. Furthermore, 
more than one third of women had multiple sexual partners, yet only 36.7% reported using 
a condom at last sex. These figures suggest a gendered vulnerability and risk: by 
comparison, among a national sample of mostly male injecting drug users in Indonesia, 
51.6% reported using a condom at last sex [18]. Together, these findings highlight drug-using 
women’s considerable risk for contracting HIV and onwards transmission to their sexual and 
injecting partners, and perinatally to infants. For these urban, low-income women, IPV 
victimization could result in increased engagement in risky sexual behavior, and therefore 
in increased vulnerability to HIV. This risk was magnified by 26% when psychological, 
physical and/or injurious, and sexual forms of IPV co-occurred. 
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The finding that IPV is associated with sexual risk behavior is consistent with results from 
previous studies [8, 51, 70]. This association may be explained by women’s limited 
capacity to negotiate safer behaviours, particularly in abusive relationships. For instance, 
research with women in methadone treatment in the U.S. found that women who insisted 
that a partner use condoms were at elevated risk of IPV victimization, since partners tended 
to perceive such requests as a breach of gender role expectations, lack of trust, sign of 
infidelity or a threat to male dominance in the relationship. In the Indonesian context, fear 
of escalating partner aggression may lead some women to acquiesce to condomless sex and 
other risky behaviors, as has been substantiated by qualitative research with women who 
inject drugs in Central Java [25]. The link between experiencing IPV and elevated sexual 
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risk-taking in Indonesia may be further shaped by social stigma, cultural norms and 
relationship power differentials [23]. Gendered cultural beliefs around placing care for an 
intimate partner above oneself, avoiding conflict, and preserving harmony in relationships 
may contribute to women’s inability to negotiate safer sex, even in situations when they feel 
they are at risk [23, 71]. Such gendered dynamics may also extend to the link between IPV 
and having multiple sexual partners. Previous studies have shown that the traumatic and 
economic consequences of being in an abusive relationship may steer women into other 
types of relationships, including survival sex work [8, 41, 46]. Women in intimate 
partnerships with drug-using partners may feel added pressure to trade sex and engage in 
risky encounters in order to maintain both their and their partners’ drug supply and to 
provide for their families [46, 72]. In the Indonesian context, this may include the practice of 
turbo (tukar body), or trading sex with drug dealers in exchange for drugs. This practice is 
common among low- income, drug-using women and may be enforced by women’s partners 
as part of a gendered division of labour [19]. 
 
Crucially, psychological and sexual IPV victimization remained independently associated 
with HIV risk-taking behavior after controlling for other dimensions of IPV. This finding 
contributes to an emerging body of research showing that psychological aggression exerts 
comparable effects to physical and/or sexual forms of IPV [11]. A reduction in effect 
estimates was observed when all forms of IPV were included in the model, which could 
reflect any of the following: collinearity, confounding, or mediating relationships between the 
variables assessed. Given the small VIF scores detected for the model, overall collinearity is 
unlikely to have impacted the effect estimates. However, confounding through additional 
variables cannot be fully ruled out in cross sectional study analyses such as this one [63]. 
Two-way interactions were assessed between all model variables and none were found. We 
can speculate about potential mediating relationships in light of past research. Women’s 
crystal meth use may mediate the complex relationship between experiencing IPV and 
HIV risk, as using different types of drugs, including stimulants, has been associated with 
both violence victimization and unsafe sexual practices [51, 73, 74]. The association between 
IPV and HIV risk may be further mediated by women’s low socio-economic status, which 
could drive women to use drugs and trade sex in perilous environments where coercive sex is 
common and safe sexual practices are challenging to negotiate [75]. Furthermore, there is 
strong evidence for the role of mental health, particularly depression and post-traumatic 
stress disorder, in both perpetuating and mediating relationships between substance use, IPV, 
and HIV [76–78]. Mental health challenges can also play a role in increasing women’s 
substance use and in inhibiting their ability to discern and navigate risky situations [79]. 
Future research among women who use drugs in low- and middle-income settings has the 
opportunity to explore these and other potential mediating mechanisms which are 
associated with both IPV and HIV risk outcomes. 
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Moreover, our findings show that crystal meth use doubled the odds of engaging in sexual 
risk behavior. This finding confirms previous research from North America [55, 80] and 
contributes to a nascent body of evidence on the link between non-injection crystal meth 
use and elevated HIV transmission risk in Indonesia [81]. This finding is particularly 
alarming considering that Indonesia has seen a surge in crystal meth use in recent years [82], 
which may be contributing to an increase in overall HIV prevalence rates. Existing HIV 
prevention interventions for women who inject drugs in Indonesia should therefore be adapted 
to better meet the needs of poly-drug and crystal meth users. 
 
Furthermore, HIV-positive status was associated with greater sexual risk-taking. Previous 
research with injecting populations has been inconclusive on the relationship between HIV 
sero-positivity and sexual risk, with studies finding both positive [83] and negative [84] 
associations. Our findings suggest that effective prevention of HIV among women who inject 
drugs and their intimate partners in Indonesia may benefit from including enhanced 
prevention efforts focusing on substance-using women who live with HIV. 
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In addition, younger women and women with a lower level of education were more likely 
to engage in sexual risk behavior. These findings support research from the U.S. 
suggesting that women’s educational and social disadvantage places them at higher risk of 
HIV transmission [5, 85]. Women’s education level plays an important role in perpetuating 
high-risk situations and gender power imbalances [85], which may be intensified in abusive 
and drug- involved relationships. 
 
 
 
Our finding that married women were less likely than their non-married counterparts to 
engage in sexual risk behavior is at odds with previous research in one regard. Specifically, 
studies have suggested that women in steady relationships, including those with high-risk 
partners, are more likely to engage in risky sex than those in casual or transactional 
partnerships [8]. 
 
The findings in this paper suggest that IPV could also influence other HIV-related health 
outcomes and merits further investigation in Asia and other regions with injection-driven 
epidemics. For instance, the same mechanisms that heighten the risk of contracting 
sexually-transmitted HIV appear to also elevate women’s injecting risk (i.e. syringe sharing 
and borrowing) and should be considered in future analyses [86, 87]. Furthermore, 
emerging research among drug-using women in Malaysia points to the adverse effects of 
IPV, co-occurring mental health challenges, and low social support on HIV testing and/or 
monitoring outcomes [53]. In the context of accumulating research on the detrimental 
effect of overlapping syndemics in perpetuating health-related disparities among women 
who use drugs [5], future research with drug-using women in Indonesia may benefit from 
investigating associations and mechanisms linking IPV with a broader range of HIV risk 
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and treatment outcomes such as viral load, enrolment, and adherence to antiretroviral 
treatment. 
 
The results of this study should be considered in the context of several limitations. First, the 
cross-sectional design prohibits assessing causality, highlighting the need for follow-up 
research employing longitudinal designs. Second, the use of self-report may be subject to 
recall and reporting bias, including the tendency to under-report stigmatised behaviors 
[88]. Longer recall periods (e.g. lifetime, past year) carry a higher risk of erroneous 
reporting than measures requiring shorter recall periods (e.g. past week, month, or three 
months). Thus, the findings are vulnerable to potential biases related to recall bias around 
sexual and injecting behaviors, which were assessed for the preceding 12 months. This 
limitation was minimised through the use of a peer recruitment strategy [89] shown to 
enhance the validity and reliability of data by improving rapport and trust and enabling 
participants to provide more honest responses [90]. Third, findings should be carefully 
interpreted in light of potential biases associated with RDS analytical methods. Since RDS 
depends on social networks for referral, some sub-populations of drug-using women (i.e. 
women injecting only with one partner) might be underrepresented in this sample due to 
having limited networks within the broader population. Furthermore, because RDS 
recruitment starts with purposively selected seeds that may or may not accurately represent 
the underlying network structure of the population, there is a risk that the resulting sample 
may be more representative of the characteristics of the seeds rather than the those of the 
target population, resulting in a form of selection bias [91]. We attempted to minimize the 
potential impact of seed selection on the estimates by monitoring convergence plots for key 
variables throughout data collection to see whether the estimates appeared to stabilize with 
successive waves of recruitment. Given that recruitment chains at both study sites converged 
to a sampling equilibrium well in advance of attaining the full sample size, we concluded that 
bias associated with the non-random recruitment of seeds was substantially eliminated. 
We paid particular attention to monitoring recruitment chains in Bandung, where only two 
seeds generated 100% of the sample size in that city and nearly 22% of the cumulative 
sample across the two study sites. The recruitment chains were long enough to ensure 
that there was no correlation of characteristics to the seed with the outcome of recruitment, 
and the recruitment process penetrated deeply into the population of women who inject 
drugs in Bandung. In addition, there was no evidence of differential recruitment activity as 
observed by low homophily scores and minimal differences in mean personal degrees for all 
variables of interest, indicating that lingering bias associated with seed dependence was 
unlikely to affect the estimates. Finally, a key theoretical assumption in RDS is that each 
sample comprises a single network component [60]. Although RDS-adjusted estimates were 
reported separately for each city, multivariate analyses were performed on the combined, 
unweighted dataset in order to retain the power and precision corresponding to the original 
calculated sample size. Therefore, while the city-level prevalence estimates fulfilled RDS 
theoretical assumptions, findings from the regression and marginal effects analyses may not 
be generalizable to other settings. 
 
http://repository.uwc.ac.za
20 
 
Notwithstanding these limitations, the data presented here constitute the best currently 
available evidence on correlates of HIV sexual risk behavior in a diverse sample of 
Indonesian women who inject drugs. This study has important programmatic implications. 
Our findings provide new insights into the sexual risk associations of different forms of IPV 
among women who inject drugs in Asia. Longitudinal data are needed to test the temporal 
relationships of associations observed in this study, and assess potential causal mechanisms 
to be subsequently addressed through intervention research. Such analyses would be the 
next step to informing evidence-based interventions and service provision. As a first step, 
IPV prevention and screening targeting women who use drugs in Indonesia should be 
integrated within existing HIV prevention and harm reduction programs. Possible 
settings for service integration include methadone maintenance clinics, community health 
centers providing HIV prevention services, and community-based drug treatment facilities. 
Ultimately, this study’s findings demonstrate an urgent need for the optimization of HIV 
prevention interventions to better respond to the high prevalence of IPV and HIV risk among 
Indonesian women who inject drugs. 
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